Home : Unsafe Drugs : Singulair

Singulair Side Effects

Name: Singulair
Generic: Montelukast
Manufacturer: Merck
Date approved: February 20, 1998
Status: Prescription only, approved status being reviewed by the FDA
Approved uses: Preventative treatment of asthma and seasonal allergies
Off-Label uses: None
Side effects:
  • Stomach pain
  • stomach or intestinal upset
  • heartburn
  • tiredness
  • fever
  • stuffy nose
  • cough
  • flu
  • upper respiratory infection
  • dizziness
  • headache
  • rash
  • possible connection to increased suicidal thoughts
Do you need a District of Columbia Singulair attorney? Contact one of our District of Columbia Singulair attorneys now.

Singulair (Montelukast)

Singulair is an asthma medication that acts by being a leukotriene inhibitor. Leukotrienes are chemicals the body releases when one breathes in an allergen (such as pollen). These chemicals cause swelling in the lungs and tightening of the muscles around airways, which can result in asthma symptoms. Singulair is proscribed to prevent asthma attacks in adults and children as young as 12 months old. It is also used to relieve runny nose and sneezing caused by allergies in adults and children as young as 6 months old.

In March 2008, reports emerged linking Singulair to increased suicidal thoughts among patients taking the medication. On March 27th, 2008, the FDA announced it was reviewing a possible connection between Singulair and suicidal behavior in adults and children, after receiving reports of mood and behavior changes, suicidal thinking and suicide in patients who had taken the drug. The FDA has recommended that until further information is available, health care professionals and caregivers should monitor patients taking Singulair for any suicidal behaviors or thoughts. Upon the completion of the investigation, the FDA will give its recommendation as to whether Singulair should continue being proscribed to asthma and allergy sufferers.

Singulair FDA Warnings - Possible Connection to Suicidal Thoughts

Singulair, generically known as montelukast sodium, is a medication manufactured and distributed through the pharmeceutical conglomerate Merck and Co. In the last year alone, Merck has changed the language on the prescribing information four times to include information on a range of newly reported side effects: tremors, anxiousness, depression and suicidal behavior. None of these symptoms were initially listed on the medication, nor did they surface in the controlled studies Merck performed in an analysis of more than 11,000 patients in 40 clinical trials. read more

Living With Asthma

There are currently almost 20 million Americans suffering from asthma, and approximately 45 percent of these individuals are children, according to the National Heart Lung and Blood Institute (NHLBI). Asthma is often associated with allergies, but not all individuals suffering from asthma also suffer from allergies. Signs and Symptoms of Asthma. read more

View the Singulair Law Articles page here

Singulair FDA Information

FDA Statement on Foodborne E. coli O157:H7 Outbreak in Spinach--Update: Wednesday, October 4, 2006

View the Singulair FDA Information page here

Singulair News Articles

Asthma and Allergy Patients Prescribed Montelukast Instead of First Line Therapy and Shows Low Rate of Persistence

logowanie - esculap

View the Singulair News Articles page here

Singulair Newsfeeds

What's Medicines Not To Take When Taking Ranitidine 150 Mg?

Earnings Preview: Merck report comes after drug OK

View the Singulair Newsfeeds page here

Singulair Wikipedia

Montelukast

Asthma

View the Singulair Wikipedia page here

Need A Singulair Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Do you need a District of Columbia Singulair attorney? Contact one of our District of Columbia Singulair attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Singulair Case - Submit Your Information Below

Do you need legal assistance with your Singulair case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Singulair Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.